Table 1.
Dose–Route d5OT |
80 IU IN | 40 IU IN | 80 IU IV | |||
---|---|---|---|---|---|---|
Monkey ID# (sex) |
ID #2 (M) |
ID #4 (M) |
ID #1 (F) |
ID #5 (F) |
ID #3 (F) |
ID #6 (F) |
Brain region | BRAIN d5OT concentration pg/mg (nM) | |||||
Cerebellum | ND | + | ND | ND | ND | ND |
Brainstem | 0.14 (<1) | 0.24 (1) | + | ND | ND | + |
Striatum | ND | ND | 2.41 (13) | + | ND | ND |
Amygdala | ND | ND | NM | + | ND | ND |
Thalamus | ND | ND | 0.23 (1) | ND | ND | ND |
Visual cortex | ND | ND | ND | ND | ND | ND |
Insular cortex | ND | ND | NM | ND | ND | ND |
dPFC | ND | + | ND | + | ND | + |
mPFC | ND | ND | ND | ND | ND | + |
OFC | 2.04 (11) | ND | ND | ND | ND | ND |
Hypothalamus | ND | ND | ND | |||
Hippocampus | ND | ND | ND |
ND not detected, NM not measured, + detected but not quantifiable, OT oxytocin, dPFC dorsal prefrontal cortex, mPFC medial prefrontal cortex, OFC orbital frontal cortex, CSF cerebrospinal fluid, F female, M male, IN intranasal, IV intravenous.